Disease Models & MechanismsDevelopmental BiologyPeer-reviewed journal article
Transgenic mouse models for investigating human DUX4 expression during development and its roles in FSHD pathophysiology
Yosuke Hiramuki, Charis L. HimedaiD, Peter L. JonesiD, Takako Iida JonesiD
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 18th percentile
Abstract
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant myopathy caused by aberrant expression of the DUX4 retrogene, and it affects skeletal muscles primarily in the face, shoulder, and limbs. In healthy individuals, DUX4 is expressed in early development and is subsequently silenced in most somatic tissues. The spatiotemporal pattern of DUX4 mis-expression beyond the cleavage stage in FSHD is poorly understood because DUX4 is not well conserved beyond primates. Here, we generated Cre reporter mouse lines with human DUX4 regulatory elements to investigate the cell lineages derived from DUX4-expressing cells in embryos and adults. Intriguingly, we found that DUX4-expressing cell lineages were present in embryonic forelimb, hindlimb, and face. In adults, the reporter was expressed strongly in testis and to a lesser extent in other tissues, including weak, sporadic expression in skeletal muscles, reminiscent of mosaic DUX4 expression in FSHD. Within skeletal muscles, DUX4 lineage cells include pericytes, an interstitial cell that contributes to muscle regeneration and repair. Overall, this study introduces a new research tool for the field, and provides new insight into potential developmental mechanisms underlying FSHD pathophysiology. Summary statementCre reporter mouse lines with human DUX4 regulatory elements are discovery tools for developmental processes and mechanisms underlying FSHD pathophysiology.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Developmental regulators drive DUX4 expression in facioscapulohumeral muscular dystrophy
Amelia Fox, Jonathan Oliva, … Francis M. Sverdrup·bioRxiv·May 21, 2024
- Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity
T. I. Jones, G.-L. Chew, … P. L. Jones·Skeletal MusclePeer-reviewed·Apr 11, 2020
- Relationship of DUX4 and target gene expression in FSHD myocytes
Jonathan Chau, Xiangduo Kong, … Kyoko Yokomori·Human MutationPeer-reviewed·Jan 27, 2021
- P38α Regulates Expression of DUX4 in Facioscapulohumeral Muscular Dystrophy
Luis Alejandro Rojas, Erin Valentine, … Owen B. Wallace·Journal of Pharmacology and Experimental TherapeuticsPeer-reviewed·Jun 23, 2020
- LEUTX mediates amplification of DUX4 signaling and aberrant myotube differentiation in facioscapulohumeral muscular dystrophy
Xiangduk Kong, Sung Jun Beck, … Kyoko Yokomori·bioRxiv·Oct 29, 2026
- An in silico FSHD muscle fibre for modelling DUX4 dynamics and predicting the impact of therapy
M. V. Cowley, J. Pruller, … C. R. S. Banerji·bioRxiv·Dec 12, 2022